Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): Eczema diagnostic patch 02 drug clinical trial application accepted.

Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ) announced that the company has received an "Acceptance Notice" from the National Medical Products Administration for the drug clinical trial application submitted by the company for the "Eczema Diagnostic Patch 02 Patch". The related indication is: used for patch testing, assisting in the diagnosis of allergic contact dermatitis related to cortisone, paraphenylenediamine, and formaldehyde sensitization.